CR7720A - 2-HYDROXI-1,3- DIAMINOALCANE OIL - Google Patents
2-HYDROXI-1,3- DIAMINOALCANE OILInfo
- Publication number
- CR7720A CR7720A CR7720A CR7720A CR7720A CR 7720 A CR7720 A CR 7720A CR 7720 A CR7720 A CR 7720A CR 7720 A CR7720 A CR 7720A CR 7720 A CR7720 A CR 7720A
- Authority
- CR
- Costa Rica
- Prior art keywords
- diaminoalcane
- hydroxi
- oil
- compounds
- disclosed
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Se divulgan compuestos de la Formula I. Donde las variables Z,X, R15, R2, R3, Rc son definidas aqui. Los compuestos divulgados aqui son inhibidores de la enzima beta secretasa y por lo tanto, son utiles para el tratamiento de la enfermedad del Alzheimer y otras enfermedades caracterizadas por la deposicion del peptido A beta en un mamifero.Compounds of Formula I are disclosed. Where the variables Z, X, R15, R2, R3, Rc are defined herein. The compounds disclosed herein are inhibitors of the beta secretase enzyme and are therefore useful for the treatment of Alzheimer's disease and other diseases characterized by the deposition of the beta A peptide in a mammal.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40945302P | 2002-09-10 | 2002-09-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR7720A true CR7720A (en) | 2005-07-14 |
Family
ID=35353421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR7720A CR7720A (en) | 2002-09-10 | 2005-03-09 | 2-HYDROXI-1,3- DIAMINOALCANE OIL |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN100384824C (en) |
AP (1) | AP2005003247A0 (en) |
CR (1) | CR7720A (en) |
TN (1) | TNSN05067A1 (en) |
ZA (1) | ZA200501991B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102010030538A1 (en) * | 2010-06-25 | 2011-12-29 | Bayer Schering Pharma Aktiengesellschaft | 6,7-Dihydro-5H-benzo [7] annulene derivatives, process for their preparation, pharmaceutical preparations containing them and their use for the preparation of medicaments |
DE102011087987A1 (en) * | 2011-12-08 | 2013-06-13 | Bayer Intellectual Property Gmbh | 6,7-Dihydro-5H-benzo [7] annulene derivatives, process for their preparation, pharmaceutical preparations containing them and their use for the preparation of medicaments |
BR112019001407A2 (en) * | 2016-07-29 | 2019-07-09 | Pgi Drug Discovery Llc | compounds and compositions and uses thereof |
CN109790079B (en) * | 2016-07-29 | 2022-06-03 | 香港科技大学 | C (sp) of organozinc reagents and heterocyclic (pseudo) halides3)-C(sp2) Cross-coupling reaction |
JP7191085B2 (en) | 2017-08-02 | 2022-12-16 | サノビオン ファーマシューティカルズ インク | Isochroman compounds and uses thereof |
CN113189089B (en) * | 2021-03-19 | 2022-05-17 | 四川轻化工大学 | Ozone detection reagent and preparation device and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5482947A (en) * | 1990-11-19 | 1996-01-09 | Talley; John J. | Retroviral protease inhibitors |
US6150416A (en) * | 1997-02-04 | 2000-11-21 | The Regents Of The University Of California | Nanomolar, non-peptide inhibitors of cathepsin D |
-
2003
- 2003-09-10 AP AP2005003247A patent/AP2005003247A0/en unknown
- 2003-09-10 CN CNB03824988XA patent/CN100384824C/en not_active Expired - Fee Related
-
2005
- 2005-03-08 TN TNP2005000067A patent/TNSN05067A1/en unknown
- 2005-03-09 ZA ZA200501991A patent/ZA200501991B/en unknown
- 2005-03-09 CR CR7720A patent/CR7720A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1694870A (en) | 2005-11-09 |
CN100384824C (en) | 2008-04-30 |
ZA200501991B (en) | 2006-01-25 |
TNSN05067A1 (en) | 2007-05-14 |
AP2005003247A0 (en) | 2005-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP055696A (en) | 2-HYDROXI-1, 3-DIAMINOALCAN OIL | |
UY28280A1 (en) | 2- HYDROXI - 3- DIAMINOALCANOS DE BENZAMIDA | |
UY28101A1 (en) | SUBSTITUTED UREAS AND USEFUL CARBAMATES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
UY28279A1 (en) | FENACILO 2 -HIDROXI - 3 - DIAMINOALCANOS | |
CR7720A (en) | 2-HYDROXI-1,3- DIAMINOALCANE OIL | |
AR025225A1 (en) | PHYSYLOXAZOLIDINONES HETEROCICLIC BICYCLIC REPLACED ANTIBACTERIAL AND PHARMACEUTICAL COMPOSITIONS | |
UY27774A1 (en) | METALOPROTEIN INHIBITORS OF TRIARIL-OXI-ARIL-ESPIROPIRIMIDINA-2,4,6-TRIONA | |
WO2005095326A3 (en) | 2-amino- and 2-thio-substituted 1,3-diaminopropanes | |
UY26480A1 (en) | N - (5 - (5 - ALKYL - 2 - OXAZOLYL) METHYL) THIO) - 2 - THIAZOLYL) - CYCLONE-DEPENDENT KINASE CARBOXAMIDE | |
ECSP055719A (en) | TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
ECSP044992A (en) | INHIBITORS OF THE ALQUÍN-ARIL FOSFODIESTERASA-4 | |
NZ516599A (en) | 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands | |
UY28450A1 (en) | 6 MEMBER HETEROARILE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS. | |
UY27338A1 (en) | NEW DERIVATIVES OF SULPHONIC ACID | |
UY26481A1 (en) | N - (5 - ((((5 - RENT - 2 - OXAZOLYL) METHYL) UNCLE) - 2 - THIAZOLYL) - CYCLONE-DEPENDENT KINASE CARBOXAMIDE. | |
FI970279A (en) | Organic compounds | |
BR0306855A (en) | Method for the treatment of cognitive disorders | |
UY27451A1 (en) | 2,5-DIAMIDOINDOLES REPLACED AND ITS USE | |
GT200300066A (en) | CYCLOPENTENE DERIVATIVES | |
UY28458A1 (en) | OXAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
NO20053562L (en) | Novel aminobenzophenone compounds | |
BR0314714A (en) | Compounds for the treatment of alzheimer's disease | |
ATE359995T1 (en) | AMINE 1,2 AND 1,3-DIOL COMPOUNDS AND THEIR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE | |
PA8558901A1 (en) | NEW HEXACICLIC COMPOUNDS | |
DE60210769D1 (en) | USE OF BICYCLIC COMPOUNDS FOR THE TREATMENT OF ALZHEIMER |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |